CORT
CORCEPT THERAPEUTICS INC
NASDAQ · Healthcare · Biotechnology · US
$79.22
−3.31%Leverage
- Debt / equity
- 0.01x
- Net debt / equity
- -0.11x
- Debt / assets
- 0.01x
- Debt / EBITDA
- 0.07x
- Net debt / EBITDA
- -0.70x
Liquidity & coverage
- Current ratio
- 3.00x
- Quick ratio
- 2.94x
- Cash ratio
- 2.09x
- Interest coverage
- —
- EBITDA / interest
- —
- Working capital
- $356.2M
Cash & dividend
- FCF / debt
- 21.65x
- Cash flow / debt
- 22.03x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Sep 1, 2026